SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-045554
Filing Date
2024-04-18
Accepted
2024-04-18 16:09:22
Documents
5
Period of Report
2024-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A catx-2024-def_14a-proxy.htm DEF 14A 1330263
2 GRAPHIC img155038979_0.jpg GRAPHIC 54290
3 GRAPHIC img155038979_1.jpg GRAPHIC 52900
4 GRAPHIC img155038979_2.jpg GRAPHIC 143064
5 GRAPHIC img155038979_3.jpg GRAPHIC 155939
  Complete submission text file 0000950170-24-045554.txt   1891600
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 (509) 375-1202
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

IRS No.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33407 | Film No.: 24854381
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)